Newsroom | 22979 results

FAIRFAX, Va.--(BUSINESS WIRE)--Ahead of spring, the National Pest Management Association (NPMA) warns that ants, termites, mosquitoes and ticks are already on the move....

PHILADELPHIA--(BUSINESS WIRE)--iECURE, Inc., a clinical-stage genome editing company developing variant-agnostic in vivo targeted gene insertion therapies for the treatment of severe, inherited, neurometabolic disorders, today announced that the U.S. Food and Drug Administration (FDA) has selected ECUR-506, the company’s investigational in vivo targeted gene insertion therapy for neonatal-onset ornithine transcarbamylase (OTC) deficiency, to participate in the Chemistry, Manufacturing, and Cont...

OXFORD, England & EDINBURGH, Scotland--(BUSINESS WIRE)--ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh’s Roslin Institute to advance veterinary immunology research through development and validation of novel species-specific Ankyron® binders. Increased understanding of animal health through the application of ProImmune’s proprietary Ankyron binding technology will enable development of new strategies for pr...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the fourth quarter and year ended December 31, 2025. “Our recent decision to advance oral epetraborole into a Phase 2 study for polycythemia vera highlights the growing opportunity across AN2’s boron chemistry pipeline and...

BALTIMORE--(BUSINESS WIRE)--Real Time Medical Systems (Real Time), the industry-leading, KLAS Rated, and HITRUST Certified post-acute analytics solution, announced today its participation in the American Association for Post-Acute Care Nursing (AAPACN) 2026 Conference, taking place March 17–20 in Orlando, FL. As nursing professionals convene to explore best practices and emerging clinical innovations, Real Time and North Shore Health will highlight how live, data-driven approaches help post-acu...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced it will present new clinical and real-world data reaffirming the long-term effectiveness of the company’s 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) and its 4-valent HPV vaccine, GARDASIL® (Human Papillomavirus 4-valent Vaccine, Recombinant) against certain HPV-related cancers and diseases at the EUROGIN Interna...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Names Kevin Haas as Chief Development and Technology Officer...

LOS ANGELES--(BUSINESS WIRE)--As Health Care is Slashed Nationwide, AHF and FLUX Create L.A. Health Care Center ‘Open for ALL’...

ALEXANDRIA, Va. & MIAMI--(BUSINESS WIRE)--AAO-HNSF and OpenEvidence use AI to update clinical practice guidelines and align standards of care with the latest clinical evidence as it evolves....

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (Nasdaq : HYFT), une société d'IA bio-native axée sur la découverte de produits biologiques et le développement de médicaments optimisé par l'IA, annonce aujourd'hui ses résultats financiers pour le troisième trimestre de l'exercice 2026, clos le 31 janvier 2026. MindWalk tiendra sa téléconférence sur les résultats du troisième trimestre de l'exercice 2026 aujourd'hui à 10h30, heure de l'Est. Le chiffre d'affaires du T3 s'établit à 4,2 mil...